Physician's First Watch

Physician's First Watch

Medical news from NEJM Journal Watch

September 1, 2015

By the Editors

The American Society of Clinical Oncology is offering new recommendations on when genetic tests for cancer...

Comments (0)

By Kelly Young

Edited by Jaye Elizabeth Hefner, MD

Sleeping fewer than 6 hours a night is associated with increased risk for developing a cold following rhinovirus exposure, according to a small, prospective study in...

Comments (0)

By the Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Clinical Practice Center: Clinical Practice: Primary care for men who have sex...

Comments (0)

By Amy Orciari Herman

Edited by Jaye Elizabeth Hefner, MD

Higher resting heart rate and lower heart rate variability are associated with functional decline in older adults, suggests a Canadian Medical Association Journal study.

Over 5000 elders with...

Comments (0)

August 31, 2015

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Clinicians should screen every adolescent for alcohol use during office visits, the American Academy of Pediatricians urges in a new clinical report published in...

Comments (0)

By the Editors

Here's a quick look at some of the major news that came out of the European Society of Cardiology Congress in London this weekend:

  • Cyclosporine Before Percutaneous Coronary Intervention? Among patients with acute anterior...

Comments (0)

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Dipeptidyl peptidase-4 (DPP-4) inhibitors, used for glucose control in patients with type 2 diabetes, may cause severe and disabling joint pain,...

Comments (0)

By the Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Clinical Practice Center: Image in Clinical Medicine: A previously...

Comments (0)

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Digoxin is not associated with all-cause mortality, according to a meta-analysis of randomized trials in the BMJ. The new finding contrasts with that from a recent meta-analysis of mostly observational studies.

Researchers examined over 40...

Comments (0)

By Kristin J. Kelley

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

The FDA has approved evolocumab (Repatha) to lower LDL cholesterol in adults with heterozygous familial hypercholesterolemia, homozygous familial hypercholesterolemia, or clinical atherosclerotic cardiovascular disease and for whom...

Comments (0)

Pages